Combined effect of complexation and pH on solubilization

被引:61
作者
Li, P
Tabibi, SE
Yalkowsky, SH [1 ]
机构
[1] Univ Arizona, Coll Pharm, Dept Pharmaceut Sci, Tucson, AZ 85721 USA
[2] NCI, Bethesda, MD 20892 USA
关键词
D O I
10.1021/js9801889
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Both pH control and complexation are widely used as solubilization techniques in drug formulation studies. Although these two techniques are often utilized in combination, few theoretical studies have shown why the combined approach would work better than either one alone. This study constructs a background in which both the pH effect and complexation constants are used to explain the synergism between these techniques. The total solubility is determined by the addition of the concentrations of the four components present in the solution: free un-ionized drug [D-u], free ionized drug [D-i], un-ionized drug complex [DuL], and ionized drug complex [DiL]. A detailed description of [D-i] and [DiL] reveals that the complexation constants and the pH at which the drug may ionize are both critical. The weakly basic drug flavopiridol is used as a test compound to examine the validity of the equation. Although the complexation constant for ionized flavopiridol (K-i = 124 M-1) is less than one-third of that of the unionized species (K-u = 445 M-1, the solubility of the ionized drug complex [DiL] is 6-fold greater than that of the un-ionized drug complex [DuL]. This unexpected result is due to the 25-fold greater solubility of the ionized drug [D-i] at pH 4.3 over that of the free un-ionized species [D-u] at pH 8.4. The results of this and other complexation studies of several drugs taken from the literature lend the support to the following: if [D-i]/[D-u] > K-u/K-i, then [DiL] > [DuL].
引用
收藏
页码:1535 / 1537
页数:3
相关论文
共 8 条
[1]  
DANNENFELSER RM, 1995, PDA J PHARM SCI TECH, V50, P356
[2]  
DIEM K, 1974, SCI TABLES, P280
[3]  
Higuchi T., 1965, Interscience, New York, V4, P117
[4]   SOLUBILIZATION OF A TRIPEPTIDE HIV PROTEASE INHIBITOR USING A COMBINATION OF IONIZATION AND COMPLEXATION WITH CHEMICALLY-MODIFIED CYCLODEXTRINS [J].
JOHNSON, MD ;
HOESTEREY, BL ;
ANDERSON, BD .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1994, 83 (08) :1142-1146
[5]   Pharmaceutical applications of cyclodextrins .1. Drug solubilization and stabilization [J].
Loftsson, T ;
Brewster, ME .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (10) :1017-1025
[6]  
Martin A.N., 1993, PHYSICAL PHARM, P233
[7]   The interaction of charged and uncharged drugs with neutral (HP-beta-CD) and anionically charged (SBE7-beta-CD) beta-cyclodextrins [J].
Okimoto, K ;
Rajewski, RA ;
Uekama, K ;
Jona, JA ;
Stella, VJ .
PHARMACEUTICAL RESEARCH, 1996, 13 (02) :256-264
[8]   SOLUBILIZATION OF THIAZOLOBENZIMIDAZOLE USING A COMBINATION OF PH ADJUSTMENT AND COMPLEXATION WITH 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN [J].
TINWALLA, AY ;
HOESTEREY, BL ;
XIANG, TX ;
LIM, K ;
ANDERSON, BD .
PHARMACEUTICAL RESEARCH, 1993, 10 (08) :1136-1143